Related Experiment Video
Updated: Aug 20, 2026
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Oncogenic role of NALP7 in testicular seminomas
Koichi Okada1, Eiji Hirota, Yoichi Mizutani
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Abstract:
To isolate novel molecular targets for treatment of testicular germ cell tumor (TGCT), we performed genome-wide expression profile analysis of testicular seminomas using a cDNA microarray. We here report identification of NACHT, leucine-rich repeat and PYD containing 7 (NALP7 ), that was significantly transactivated in testicular seminomas. Subsequent semi-quantitative RT-PCR and northern blot analyses confirmed an approximately 3.3-kb transcript that was expressed exclusively in testis, although the expression level of this gene in normal testis was much lower than in tumor cells, suggesting an important role of this gene in germ-cell proliferation. Immunohistochemical analysis using anti-NALP7 polyclonal antibody detected the endogenous NALP7 protein in the cytoplasm of embryonal carcinoma cells and testicular seminoma tissues. Transfection of small interfering RNA (siRNA) for NALP7 significantly reduced the NALP7 expression and resulted in growth suppression of testicular germ-cell tumors. These findings imply that NALP7 may play a crucial role in cell proliferation, as well as testicular tumorigenesis, and it appears to be a promising candidate for development of targeted therapy for TGCTs.
Insights
Researchers identified NACHT, leucine-rich repeat and PYD containing 7 (NALP7) as a key gene in testicular germ cell tumors (TGCTs). NALP7 promotes TGCT proliferation and may be a target for new therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Testicular germ cell tumors (TGCTs) are the most common cancer in young men.
- Identifying novel molecular targets is crucial for developing effective TGCT treatments.
Purpose of the Study:
- To identify novel molecular targets for TGCT treatment.
- To investigate the role of NACHT, leucine-rich repeat and PYD containing 7 (NALP7) in TGCT development and proliferation.
Main Methods:
- Genome-wide expression profile analysis using cDNA microarray.
- Semi-quantitative RT-PCR and Northern blot analysis to confirm NALP7 transcript expression.
- Immunohistochemical analysis to detect NALP7 protein localization.
- Small interfering RNA (siRNA) transfection to assess NALP7's functional role in tumor growth.
Main Results:
- NALP7 was significantly upregulated in testicular seminomas compared to normal testis.
- A specific 3.3-kb NALP7 transcript was exclusively detected in the testis.
- NALP7 protein was localized in the cytoplasm of embryonal carcinoma cells and TGCT tissues.
- siRNA-mediated knockdown of NALP7 suppressed TGCT cell proliferation.
Conclusions:
- NALP7 plays a critical role in testicular germ cell tumor proliferation and tumorigenesis.
- NALP7 is a promising molecular target for the development of targeted therapies for TGCTs.
Related Concept Videos
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:55The Nucleolus
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...